Dual Antiplatelet Agents Therapy in the Emergency Department for Acute Coronary Syndrome (The DATES Study).
Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY
This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult patients
• Presenting with acute coronary syndrome (ST segment elevation myocardial infarction, non ST segment elevation myocardial infarction, and unstable angina).
• Antiplatelet medication (s) prescribed during index admission to hospital.
• Willingness of the patient to be called for follow up up to 1 year after index hospitalization.
Locations
Other Locations
Jordan
Istishari Hospital
NOT_YET_RECRUITING
Amman
Jordan University Hospital
RECRUITING
Amman
Contact Information
Primary
Ayman Hammoudeh, MD, FACC
hammoudeh_ayman@yahoo.com
+96265001000
Backup
Laith Habahbeh, MD
researchcultire2020@gmail.com
065001000
Time Frame
Start Date: 2025-08-01
Estimated Completion Date: 2026-11-01
Participants
Target number of participants: 200
Treatments
Adult patients admitted for acute coronary syndrome via the ED
Patients with ACS presenting to the ED with a planned coronary angiography for possible coronary revascularization who get aspirin in the ED will be evaluated for bleeding and major cardiovascular events when they receive a second antiplatelet agent in the ED compared with in the cath lab.
Related Therapeutic Areas
Sponsors
Leads: Jordan Collaborating Cardiology Group